In acute myocardial infarction, should dual antiplatelet therapy (DAPT) include loading doses of both aspirin and ticagrelor?

Yes, load both aspirin and ticagrelor in acute myocardial infarction

In acute myocardial infarction, you must administer loading doses of both aspirin (162-325 mg) and ticagrelor (180 mg) as soon as possible on presentation. This dual loading strategy is a Class 1 recommendation from the 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines 1, 2.

Loading Dose Specifications

Aspirin:

• Loading dose: 162-325 mg orally 1
• Should be chewed (non-enteric coated) for faster onset of antiplatelet action
• Administer even if patient is already on daily aspirin therapy
• Maintenance: 75-100 mg daily thereafter

Ticagrelor:

• Loading dose: 180 mg orally 1
• Maintenance: 90 mg twice daily
• Acts within 30 minutes, providing rapid platelet inhibition 3

Clinical Reasoning

The guideline evidence is unequivocal: both agents require loading doses because:

1. Aspirin loading achieves immediate thromboxane A₂ suppression, which is critical in the acute thrombotic phase of MI 2

2. Ticagrelor loading provides rapid P2Y12 receptor inhibition—far superior to clopidogrel which takes 2 hours versus 30 minutes for ticagrelor 3

3. Timing matters: The earlier you load both agents, the better. Recent evidence shows prehospital DAPT loading (both aspirin and ticagrelor) achieved superior TIMI 3 flow (91.4% vs 82.2%, p=0.007) and reduced 30-day MACE (5.4% vs 11.2%, p=0.038) compared to in-hospital administration 4

Management Strategy by Clinical Scenario

For STEMI with primary PCI:

• Load both aspirin AND ticagrelor immediately (Class 1) 1
• Ticagrelor preferred over prasugrel or clopidogrel 1

For NSTE-ACS undergoing PCI:

• Load both aspirin AND ticagrelor (Class 1) 1
• Alternative: prasugrel loading (60 mg) if ticagrelor unavailable

For STEMI receiving fibrinolytic therapy:

• Load aspirin (162-325 mg) 1
• Load clopidogrel (300 mg if age ≤75 years; 75 mg if age >75 years) 1
• Note: Ticagrelor/prasugrel not studied with fibrinolytics; switch to ticagrelor can be considered at time of PCI if performed

Critical Caveats

Aspirin dose with ticagrelor: Maintenance aspirin must be ≤100 mg daily when using ticagrelor, as higher doses reduce ticagrelor's efficacy (post-hoc PLATO analysis) 1, 2

Contraindications to consider:

• Prasugrel (not ticagrelor): absolutely contraindicated if history of stroke/TIA due to increased cerebrovascular events (6.5% vs 1.2%, p=0.002) 1, 3
• Active bleeding is the main contraindication to loading either agent

Drug interactions: The FDA label notes ticagrelor is contraindicated with strong CYP3A4 inhibitors like itraconazole 5, though this rarely impacts acute MI management

Bleeding Risk Consideration

While ticagrelor increases bleeding compared to clopidogrel, the loading strategy itself (both agents together) is standard practice. The 2025 guidelines explicitly recommend this approach without bleeding-risk stratification affecting the initial loading decision 1. Bleeding risk considerations apply to duration of DAPT (discussed at discharge), not whether to load both agents acutely.

The evidence is clear: load both agents immediately to maximize early platelet inhibition and improve outcomes in acute MI.